Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Moxifloxacin nitrosamine impurity 3 | Details |
| Finerenone Impurity 10 | C23H28N4O4 | 2640280-83-5 | Details |
| 4-Amino-2-hydroxy-5-methylpyridine | C6H8N2O | 95306-64-2 | Details |
| (1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate | C13H15FO3 | 1369768-29-5 | Details |
| Paroxetine Impurity 5 | C13H18FNO | 100332-20-5 | Details |
| 4-CHLORO-3,5-DIAMINOBENZOIC ACID | C7H7ClN2O2 | 69236-82-4 | Details |
| 10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine | C20H25N3S | 84-97-9 | Details |
| Lenalidomide Impurity 22 | C13H13N3O4 | 2717380-87-3 | Details |
| 3-hydroxy-Octanedioic acid | C8H14O5 | 73141-47-6 | Details |
| Dapagliflozin Impurity 178 | Details |
| ent-Paroxol | C13H18FNO | 389573-45-9 | Details |
| 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid | C21H21N3O4 | 1050477-45-6 | Details |
| Landiolol Impurity | Details |
| 2'-(Methylthio)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one | C15H18N4OS | 2170747-00-7 | Details |
| benzyl (3S,4R)-3-(2-chloroacetyl)-4-ethylpyrrolidine-2-carboxylate | C16H20BrNO3 | 2304514-69-8 | Details |
| N-tert-butyldibenzylamine | C18H23N | 30923-82-1 | Details |
| 6-amino-5-formamido-1,3-dimethyluracil | C7H10N4O3 | 7597-60-6 | Details |
| Raffinazine Impurity B | Details |
| Esmolol Hydrochloride impurity 2 | C18H29NO4 | 116144-60-6 | Details |
| 1,3-bis(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)urea | Details |
| 2,4-Dichlorophenylacetic acid | C8H6Cl2O2 | 19719-28-9 | Details |
| 2-chloro-5-Methyl-4-nitropyridine | C6H5ClN2O2 | 97944-45-1 | Details |
| 4,4'-(1,2-Diphenylethene-1,2-diyl)diphenol | C26H20O2 | 68578-79-0 | Details |
| Lys-Lys dihydrochloride | C12H27ClN4O3 | 52123-30-5 | Details |
| Nalpha-Acetyl-D-asparagine | C6H10N2O4 | 26117-27-1 | Details |
| 2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole | C14H12ClN3S | 103312-62-5 | Details |
| (3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl acetate | C11H12F3NO3 | 112525-75-4 | Details |
| N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide | C25H22F6N4O2S | 1083100-27-9 | Details |
| Piperacillin Impurity J | Details |
| 3-Hydroxy-4-Methyl-2(5H)-thiophenone | C5H6O2S | 34876-35-2 | Details |
| 1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)cyclopropanecarboxylic acid | C17H17FN2O3 | 1369769-35-6 | Details |
| GLYCINE ANHYDRIDE | C4H6N2O2 | 106-57-0 | Details |
| Glycylglycine | C4H8N2O3 | 556-50-3 | Details |
| Vildagliptin Impurity C | C17H26N2O4 | 565453-40-9 | Details |
| Lansoprazole Sulfone N-Oxide | C16H14F3N3O4S | 953787-54-7 | Details |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate | C22H20N4O4 | 1050477-43-4 | Details |
| Flucloxacillin EP Impurity B | C18H19ClFN3O4S | 1276016-89-7 | Details |
| Glycyl-glycyl-glycine | C6H11N3O4 | 556-33-2 | Details |
| Daunorubicin EP Impurity B | Details |
| 2'-(Methylsulfonyl)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one | C15H18N4O3S | 2170747-01-8 | Details |
| (1S,2R)-1-(3-Fluorophenyl)-2-(hydroxymethyl)cyclopropanecarbonitrile | C11H10FNO | 1450904-98-9 | Details |
| Salbutamol Impurity E | C20H27NO3 | 24085-03-8 | Details |
| DeoxyBenzoinOxime | C14H13NO | 952-06-7 | Details |
| Pinaverium Bromide Impurity | Details |
| benzyl (3S,4R)-3-ethyl-4-(2-(methylsulfinyl)acetyl)pyrrolidine -1-carboxylate | Details |
| DL-ALPHA-AMINO-EPSILON-CAPROLACTAM | C6H12N2O | 671-42-1 | Details |
| 2-Hydroxyethylhydrazine | C2H8N2O | 109-84-2 | Details |
| 2,2'-Binaphthalene-6,6'-dicarboxylic Acid | C22H14O4 | 932033-58-4 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| Canagliflozin Impurity 8 | C15H14Br2O | 1807632-93-4 | Details |
| 4-formyl-3-methoxybenzoic acid | C9H8O4 | 80893-99-8 | Details |
| benzyl (3R,4S)-3-(N-(tert-butoxycarbonyl)-N-(5-tosyl-5H- pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate | C34H39N5O7S | 1428243-27-9 | Details |
| Dapoxetine impurity | C30H32ClNO2 | 2242008-38-2 | Details |
| Tamoxifen Impurity 2 | C11H17NO3S | 123091-15-6 | Details |
| Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-, 1,1-dimethylethyl ester | C20H26N4O3S | 2170746-99-1 | Details |
| benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate | C16H20BrNO3 | 2304514-60-9 | Details |
| Acetylcysteine EP Impurity D | C7H11NO4S | 18725-37-6 | Details |
| 5-tosyl-5H-pyrrolo[2,3-b]pyrazine | C13H11N3O2S | 1944483-53-7 | Details |
| Ezetimibe Impurity O | C24H21F2NO3 | 1798008-25-9 | Details |
| 2-METHYL-N-(PHENYLMETHYLENE)-2-PROPYLAMINE | C11H15N | 6852-58-0 | Details |
| 8-HYDROXY-3,4-DIHYDRO-2-QUINOLINONE | C9H9NO2 | 52749-50-5 | Details |
| Moxifloxacin nitrosamine impurity 4 | Details |
| Finerenone Impurity 17 | C22H26N4O4 | 2640280-82-4 | Details |
| 5-aminothiazolo[4,5-d]pyrimidin-2(3H)-one | C5H4N4OS | 848691-22-5 | Details |
| Ethyl 3-anilinobut-2-enoate | C12H15NO2 | 6287-35-0 | Details |
| 1-MONOBUTYRIN | C7H14O4 | 557-25-5 | Details |
| Cefradine EP Impurity G | C13H18N2O4S | 146794-70-9 | Details |
| Dapoxetine iMpurity | C19H16O | 94305-25-6 | Details |
| 4-Cyano-2-Methoxybenzoic acid | C9H7NO3 | 89469-52-3 | Details |
| 4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one | C8H11N3O4S | 160552-54-5 | Details |
| 3-Amino-2-oxazolidinone | C3H6N2O2 | 80-65-9 | Details |
| 4-Formyl-3-methoxybenzamide | C9H9NO3 | 1289153-30-5 | Details |
| (3S,4R)-3-ethyl-4-(6-ethyl-6,9a-dihydro-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | Details |
| ALLURA RED | C18H17N2NaO8S2 | 25956-17-6 | Details |
| (±)-Rivaroxaban | C19H18ClN3O5S | 482306-32-1 | Details |
| (R)-4-Propyldihydrofuran-2(3H)-one | C7H12O2 | 63095-51-2 | Details |
| Iminodiacetic acid | C4H7NO4 | 142-73-4 | Details |
| 2-(chloromethyl)-3-methylpyridin-4-ol | C7H8ClNO | 1805648-51-4 | Details |
| (S,S)-2,8-Diazabicyclo[4,3,0]nonane | C7H14N2 | 151213-40-0 | Details |
| Valsartan Related Compound A | C24H29N5O3 | 137862-87-4 | Details |
| 6-Hydroxy-2(1H)-3,4-dihydroquinolinone | C9H9NO2 | 54197-66-9 | Details |
| Mono-POC Isopropyl Tenofovir | C21H32N5O11P | 1422284-15-8 | Details |
| Mono-POC Tenofovir | C14H22N5O7P | 211364-69-1 | Details |
| 3-acetylphenyl ethyl(methyl)carbamate | C12H15NO3 | 855300-09-3 | Details |
| Dapagliflozin Impurity 68 | C15H12BrClO2 | 1404477-10-6 | Details |
| 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | C13H21ClN2O2 | 105601-13-6 | Details |
| 2-HYDROXYBENZOIC ACID 4-(ACETYLAMINO)PHENYL ESTER | C15H13NO4 | 118-57-0 | Details |
| ethyl 2-(methylthio)-4-(3-oxo-1,4-diazaspiro[5.5]undecan-1-yl)pyrimidine-5-carboxylate | C17H24N4O3S | 2170746-95-7 | Details |
| 4-Dimethylaminopyridine | C7H10N2 | 1122-58-3 | Details |
| Raffinazine Impurity C | Details |
| Moxifloxacin nitrosamine impurity 2 | Details |
| Nitroglycerin solution EP impurity B | C3H7NO5 | 624-43-1 | Details |
| Finerenone Impurity 8 | C19H18N4O3 | 2087452-81-9 | Details |
| 2-(chloromethyl)-2-methyl-1,3-Propanediol | C5H11ClO2 | 21139-44-6 | Details |
| Benzoic acid, 2-(acetyloxy)-, 4-aminophenyl ester | C15H13NO4 | 63949-11-1 | Details |
| Rivastigmine Related Compound G | Details |
| Lemborexant Impurity 6 | 2541020-19-1 | Details |
| Doxapram N-Oxide | C24H30N2O3 | 2724726-82-1 | Details |
| Benzenemethanol, 2-(hydroxyamino)- | C7H9NO2 | 41882-63-7 | Details |
| Product Total： Product Page： | ||||
| 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 | ||||